Terms: = Endocrine gland cancer AND HIF1A, Q16665, 3091, ENSG00000100644, MOP1, HIF1-ALPHA, PASD8, HIF-1alpha
636 results:
1. OTUB2 silencing promotes ovarian cancer via mitochondrial metabolic reprogramming and can be synthetically targeted by CA9 inhibition.
Nan Y; Wu X; Luo Q; Chang W; Zhao P; Zhang L; Liu Z
Proc Natl Acad Sci U S A; 2024 May; 121(19):e2315348121. PubMed ID: 38701117
[TBL] [Abstract] [Full Text] [Related]
2. Identification of core genes of craniopharyngioma angiogenesis based on single-cell nuclear transcriptome sequencing.
Zhang J; Xu L; Ye J; Xu C; Wu B; Wu J; Hong T
Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):136-141. PubMed ID: 38650143
[TBL] [Abstract] [Full Text] [Related]
3. Glycolysis and tumor progression promoted by the m
Yang K; Zhong Z; Zou J; Liao JY; Chen S; Zhou S; Zhao Y; Li J; Yin D; Huang K; Li Y
Cancer Lett; 2024 May; 590():216840. PubMed ID: 38604311
[TBL] [Abstract] [Full Text] [Related]
4. The CREB1/WNK1 axis promotes the tumorigenesis of ovarian cancer via regulating HIF-1.
Ma Y; Zong H; Pan P; Shang H; Yang X
Exp Cell Res; 2024 May; 438(1):114006. PubMed ID: 38599542
[TBL] [Abstract] [Full Text] [Related]
5. The MUC1-HIF-1α signaling axis regulates pancreatic cancer pathogenesis through polyamine metabolism remodeling.
Murthy D; Attri KS; Suresh V; Rajacharya GH; Valenzuela CA; Thakur R; Zhao J; Shukla SK; Chaika NV; LaBreck D; Rao CV; Hollingsworth MA; Mehla K; Singh PK
Proc Natl Acad Sci U S A; 2024 Apr; 121(14):e2315509121. PubMed ID: 38547055
[TBL] [Abstract] [Full Text] [Related]
6. NNT-AS1 in CAFs-derived exosomes promotes progression and glucose metabolism through miR-889-3p/HIF-1α in pancreatic adenocarcinoma.
Zhang P; Wang Q; Lu W; Zhang F; Wu D; Sun J
Sci Rep; 2024 Mar; 14(1):6979. PubMed ID: 38521881
[TBL] [Abstract] [Full Text] [Related]
7. cancer-associated fibroblast-secreted FGF7 as an ovarian cancer progression promoter.
Feng S; Ding B; Dai Z; Yin H; Ding Y; Liu S; Zhang K; Lin H; Xiao Z; Shen Y
J Transl Med; 2024 Mar; 22(1):280. PubMed ID: 38491511
[TBL] [Abstract] [Full Text] [Related]
8. Expression of HIF-1α, Ki67, SMA and E-cadherin in endometriosis, endometrial and ovarian carcinoma.
Markov D; Poryazova E; Raycheva R; Markov G
Folia Med (Plovdiv); 2024 Feb; 66(1):97-103. PubMed ID: 38426471
[TBL] [Abstract] [Full Text] [Related]
9. hif1a transcriptional regulation of COX4I2 impacts angiogenesis in pheochromocytoma.
Li X; Zhuo R; Mao Y; Fang C; Dai J; Ye L; Wang C; Sun F
Biochem Biophys Res Commun; 2024 Apr; 704():149638. PubMed ID: 38422899
[TBL] [Abstract] [Full Text] [Related]
10. Concomitant [
Kepes Z; Hegedus E; Sass T; Csikos C; Szabo JP; Szugyiczki V; Hajdu I; Kertesz I; Opposits G; Imrek J; Balkay L; Kalman FK; Trencsenyi G
In Vivo; 2024; 38(2):574-586. PubMed ID: 38418132
[TBL] [Abstract] [Full Text] [Related]
11. Essential role of PLD2 in hypoxia-induced stemness and therapy resistance in ovarian tumors.
Muñoz-Galván S; Verdugo-Sivianes EM; Santos-Pereira JM; Estevez-García P; Carnero A
J Exp Clin Cancer Res; 2024 Feb; 43(1):57. PubMed ID: 38403587
[TBL] [Abstract] [Full Text] [Related]
12. Effect of hypoxia‑HIF‑1α‑periostin axis in thyroid cancer.
Yang Y; Wu J; Zhu H; Shi X; Liu J; Li Y; Wang M
Oncol Rep; 2024 Apr; 51(4):. PubMed ID: 38391012
[TBL] [Abstract] [Full Text] [Related]
13. HIF-2α-dependent TGFBI promotes ovarian cancer chemoresistance by activating PI3K/Akt pathway to inhibit apoptosis and facilitate DNA repair process.
Ma S; Wang J; Cui Z; Yang X; Cui X; Li X; Zhao L
Sci Rep; 2024 Feb; 14(1):3870. PubMed ID: 38365849
[TBL] [Abstract] [Full Text] [Related]
14. Integrated bioinformatics approaches and expression assays identified new markers in pituitary adenomas.
Motlagh PE; Jamali E; Karimi N; Eslami S; Sharifi G; Ghafouri-Fard S
Pathol Res Pract; 2024 Mar; 255():155193. PubMed ID: 38364650
[TBL] [Abstract] [Full Text] [Related]
15. Metabolomic Investigations into Hypoxia-Mediated Metabolic Reprogramming of Pancreatic cancer Cells.
Chumak V; Rajacharya GH; Singh PK
Methods Mol Biol; 2024; 2755():191-200. PubMed ID: 38319579
[TBL] [Abstract] [Full Text] [Related]
16. ALDH1A3 contributes to tumorigenesis in high-grade serous ovarian cancer by epigenetic modification.
Huang J; Tang Y; Li Y; Wei W; Kang F; Tan S; Lin L; Lu X; Wei H; Wang N
Cell Signal; 2024 Apr; 116():111044. PubMed ID: 38211842
[TBL] [Abstract] [Full Text] [Related]
17. cancer-associated fibroblasts promote stemness maintenance and gemcitabine resistance via HIF-1α/miR-21 axis under hypoxic conditions in pancreatic cancer.
Deng K; Zou F; Xu J; Xu D; Luo Z
Mol Carcinog; 2024 Mar; 63(3):524-537. PubMed ID: 38197482
[TBL] [Abstract] [Full Text] [Related]
18. β-catenin/TCF4-induced SCUBE3 upregulation promotes ovarian cancer development via HIF-1 signaling pathway.
Shen J; Ma X; Wei Z; Qian Q; Jing A; Ding Y; Geng T; Qin J; Ma L; Chen Y; Ji J; Liu B; Huang J
Mol Cell Endocrinol; 2024 Mar; 582():112127. PubMed ID: 38109990
[TBL] [Abstract] [Full Text] [Related]
19. Research progress on the mechanism of glycolysis in ovarian cancer.
Li C; Liu FY; Shen Y; Tian Y; Han FJ
Front Immunol; 2023; 14():1284853. PubMed ID: 38090580
[TBL] [Abstract] [Full Text] [Related]
20. In vitro and In vivo evidence demonstrating chronic absence of Ref-1 Cysteine 65 impacts Ref-1 folding configuration, redox signaling, proliferation and metastasis in pancreatic cancer.
Mijit M; Kpenu E; Chowdhury NN; Gampala S; Wireman R; Liu S; Babb O; Georgiadis MM; Wan J; Fishel ML; Kelley MR
Redox Biol; 2024 Feb; 69():102977. PubMed ID: 38056311
[TBL] [Abstract] [Full Text] [Related]
[Next]
